Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

BioHarvest Sciences says it has produced a “meaningful” amount of cannabis without growing the plant

The company said the full-spectrum cannabis biomass produced solves the major industry challenges of consistency, safety, and environmental sustainability

BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) said it has produced 10 kilograms of full-spectrum cannabis biomass at a commercial scale without growing the plant itself.

The company noted that a “meaningful” amount of cannabis was produced, which it says is an industry and academia first. The cannabis produced has a trichomes density of up to 200 times greater than in a plant-grown product and solves the major industry challenges of consistency, safety, and environmental sustainability.

“The legal cannabis industry has been waiting for this moment as many of the challenges it has faced are being resolved using BioHarvest's technology and capabilities,” BioHarvest CEO Ilan Sobel said in a statement.

READ: BioHarvest Sciences says its new manufacturing facility receives GMP certification from Israeli Ministry of Health

“With this milestone, we are ready to start engaging with key players in the global cannabis industry for the right partnerships ahead of the introduction of our new cannabis products,” Sobel added.

BioHarvest said the cannabis biomass is not genetically modified and was produced using the company's proprietary BioFarming technology platform, which grows plant cells in their natural structure in proprietary bioreactors.

It added that the biomass consists of cannabis cells, which include cannabis trichome cells containing cannabinoids such as CBD, THC, as well as other compounds that are naturally occurring in the cannabis plant.

The company noted its next stage will consist of producing cannabis biomass in industrial-scale bioreactors, in which the offering will consist of multiple strains, carefully selected based on specific indications and business to business (B2B) customer requirements.

BioHarvest Sciences has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at an industrial scale, without the need to grow the plant itself.

Contact Sean at sean@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK